Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam Morgan currently holds 123,737 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Morgan has been a net buyer of HRTX stock. They have purchased $8.4M and sold $0 worth of shares.
Adam Morgan's most recent insider trade was on Jan 30, 2026, when they sold 53,960 shares at $0.00 per share.
Adam Morgan serves as Executive at HERON THERAPEUTICS, INC. /DE/ (HRTX). They have executed 10 insider transactions totaling $8.4M over their tenure at the company.
Adam Morgan holds the position of Executive at HERON THERAPEUTICS, INC. /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Adam Morgan has shown a buying trading pattern, with $8.4M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Adam Morgan was on Aug 15, 2023, when they sold $8.2M worth of ALIM shares. This transaction involved 4,845,392 shares at $1.70 per share.
Adam Morgan currently owns 123,737 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam Morgan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam Morgan has 10 Form 4 filings on record as an insider at HERON THERAPEUTICS, INC. /DE/.
Set alerts for Adam Morgan and 40,000+ other insiders.